Tag: pfizer
Pfizer (PFE): Declines in COVID-19 products expected to drag down overall revenue in 2023
Shares of Pfizer Inc. (NYSE: PFE) were down on Tuesday despite the company delivering better-than-expected results for the first quarter of 2023. The stock has dropped 24% year-to-date. The company […]
The post Pfizer (PFE): Declines in COVID-19 products expected to drag down overall revenue in 2023 first appeared on AlphaStreet.
Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts
Pfizer (PFE) expects COVID franchise to reach low point in 2023 and then rebound in 2024
Shares of Pfizer Inc. (NYSE: PFE) were up on Tuesday despite the company delivering mixed results for the fourth quarter of 2022 and providing an underwhelming guidance for the upcoming […]
The post Pfizer (PFE) expects COVID franchise to reach low point in 2023 and then rebound in 2024 first appeared on AlphaStreet.
Hewlett Packard Enterprise adds former Pfizer CFO to its board
ORIC Pharmaceuticals surges 43% on Pfizer collaboration, investment
Pfizer to invest €1.2bn in Dublin and hire for hundreds of jobs
The company plans to hire for up to 500 roles, bringing its total headcount in Ireland to around 5,500.
Read more: Pfizer to invest €1.2bn in Dublin and hire for hundreds of jobs
Pfizer Study Says the Updated COVID Boosters Significantly Rev Up Protection
Booster doses tweaked to target the most common omicron strain rolled out in early September, and the Food and Drug Administration said the latest data should spur more Americans to get one — especially before another expected wave of cases as people travel for Thanksgiving. Pfizer said people 55 and older who got the omicron-targeting booster had four-fold higher antibody levels than those given an extra dose of the original vaccine….
A month after receiving the new booster, antibody levels in people 55 and older had jumped 13 times higher than before the extra dose. Younger adults saw a 9.5-fold jump, Pfizer and its partner BioNTech said. It had been about 11 months since the study participants’ last vaccination….
The new data “reassures us that this was a good decision to move to this bivalent vaccine,” FDA vaccine chief Dr. Peter Marks told The Associated Press. “Right now is the time for people to consider going out and get the updated” booster…. The updated doses are combination shots, tailored to offer a boost of protection against both the original coronavirus strain and the dominant BA.5 strain.
Read more of this story at Slashdot.